Bio-Rad Laboratories, Inc. (BIO) Stock

Bio-Rad Laboratories, Inc. (BIO) is a Technology stock trading at $282.40 (as of 2026-06-18), with a market capitalization of $8.25B and a trailing P/E of 47.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Bio-Rad Laboratories manufactures and distributes life science research and clinical diagnostic products, including reagents, instruments, and informatics systems. It operates in Life Science and Clinical Diagnostics segments, serving research institutions, pharmaceutical and biotech companies, clinical laboratories, and food producers/testing labs across multiple regions.

Valuation — source: SEC EDGAR (first-party)
Price$282.40
Market Cap$8.25B
P/E Ratio47.6
EV / EBITDA35.9
Price / Book1.13
Price / Sales2.98
DCF Value (model)$321.93
DCF Upside vs Price14.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$2.58B
Net Margin29.4%
Return on Equity2.5%
Debt / Equity0.12
Current Ratio3.21
Revenue Growth (YoY)0.7%
EPS Growth (YoY)-142.6%
FCF Growth (YoY)29.4%
Financial Health — source: SEC EDGAR
Altman Z-Score3.09 (safe)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Stock P/E47.6
Sector P/E (Technology)32.6
Industry P/E (Measuring & Control Equipment)60.1
vs Sector45.7%
vs Industry-20.8%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderFirst Eagle Investment Management, LLC ($725.52M)
Institutional Holders Tracked10
Congressional Trades (recent)6
Company
SectorTechnology
IndustryMeasuring & Control Equipment
CEONorman D. Schwartz
Employees7,700
CountryUS
IPO Date1980-02-27

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Revvity, Inc. (RVTY)
  • Baxter International Inc. (BAX)
  • Repligen Corporation (RGEN)
  • Onto Innovation Inc. (ONTO)
  • Avantor, Inc. (AVTR)
  • Bruker Corporation (BRKR)
  • Masimo Corporation (MASI)
  • Glaukos Corporation (GKOS)
BIO earnings history · BIO institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.